Cullinan Therapeutics Inc... (CGEM)
NASDAQ: CGEM
· Real-Time Price · USD
6.29
-0.06 (-0.94%)
At close: Sep 16, 2025, 3:59 PM
6.41
1.91%
After-hours: Sep 16, 2025, 05:45 PM EDT
-0.94% (1D)
| Bid | 6.25 |
| Market Cap | 371.58M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -206.76M |
| EPS (ttm) | -3.16 |
| PE Ratio (ttm) | -1.99 |
| Forward PE | -1.77 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.78 |
| Volume | 436,278 |
| Avg. Volume (20D) | 416,461 |
| Open | 6.33 |
| Previous Close | 6.35 |
| Day's Range | 6.24 - 6.47 |
| 52-Week Range | 6.24 - 18.62 |
| Beta | -0.07 |
| Ex-Dividend Date | n/a |
About CGEM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CGEM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CGEM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+7.66%
Cullinan Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
11 months ago
+8.44%
Cullinan Therapeutics shares are trading higher after the FDA cleared the company's IND application for CLN-978.
